---
title: "Fresenius Kabi and Phlow Partner to Secure U.S. Epinephrine Supply"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/275321361.md"
datetime: "2026-02-09T13:03:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275321361.md)
  - [en](https://longbridge.com/en/news/275321361.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275321361.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/275321361.md) | [繁體中文](https://longbridge.com/zh-HK/news/275321361.md)


# Fresenius Kabi and Phlow Partner to Secure U.S. Epinephrine Supply

Fresenius SE & Co. KGaA, through its operating company Fresenius Kabi, has entered a partnership with U.S.-based manufacturer Phlow Corp. to create a fully domestic, end-to-end supply chain for Epinephrine Injection, USP. Under the agreement, Phlow will produce the active pharmaceutical ingredient (API) in the United States, while Fresenius Kabi will handle the manufacturing of finished doses for hospitals and clinics nationwide. This collaboration aims to address frequent shortages of this essential medicine and strengthen pharmaceutical security in the U.S. Epinephrine produced through this initiative could become available to U.S. hospitals as early as 2027, pending regulatory approvals. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fresenius SE & Co. KGaA published the original content used to generate this news brief on February 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相关股票

- [Fresenius SE & Co. KGaA (FRE.DE)](https://longbridge.com/zh-CN/quote/FRE.DE.md)

## 相关资讯与研究

- [Capital Group Companies Reduces Voting Rights in Fresenius SE & Co. KGaA to 3.04%](https://longbridge.com/zh-CN/news/273733463.md)
- [BlackRock Decreases Total Voting Rights in Fresenius SE & Co. KGaA to 5.09%](https://longbridge.com/zh-CN/news/275581082.md)
- [08:12 ETDEUS EX MACHINA Expands Ingredient Upscaling Platform Through Pilot Collaborations and Beta Program, Targets Q3 2026 Launch](https://longbridge.com/zh-CN/news/281635595.md)
- [05:00 ETFolly Launches First Pill-Strength Hair Health Gummy](https://longbridge.com/zh-CN/news/281494030.md)
- [BASF Pharma Solutions announces global price adjustment for pharmaceutical excipients and selected APIs](https://longbridge.com/zh-CN/news/281006696.md)